|
Federal
Register Notices > Notices of
Registration - 2007
>
Mallinckrodt Inc
FR Doc E7-9619 [Federal Register: May 18, 2007 (Volume 72, Number 96)]
[Notices] [Page 28075] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18my07-99]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated January 23, 2007, and published in the Federal Register on
January 30, 2007, (72 FR 4298), Mallinckrodt Inc., 3600 North Second Street, St.
Louis, Missouri 63147, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedule I and II:
|
Drug
|
Schedule
|
|
Codeine-N-oxide (9053)
|
I
|
|
Difenoxin (9168)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Morphine-N-oxide (9307)
|
I
|
|
Norlevorphanol (9634)
|
I
|
|
Normorphine (9313)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Nabilone (7379)
|
II
|
|
Alfentanil(9737)
|
II
|
|
Amphetamine (1100)
|
II
|
|
Ecgonine (9180)
|
II
|
|
Codeine (9050)
|
II
|
|
Dextropropoxyphene, bulk(9273)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Diphenoxylate (9170)
|
II
|
|
Diprenorphine (9058)
|
II
|
|
Etorphine HCL (9059)
|
II
|
|
Fentanyl(9801)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Levorphanol(9220)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone intermediate (9254)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Metopon (9260)
|
II
|
|
Morphine (9300)
|
II
|
|
Opium extracts (9610)
|
II
|
|
Opium fluid extract (9620)
|
II
|
|
Opium tincture (9630)
|
II
|
|
Opium, granulated (9640)
|
II
|
|
Opium, powdered (9639)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Noroxymorphone (9668)
|
II
|
|
Phenazocine (9715)
|
II
|
|
Alfentanil(9737)
|
II
|
|
Remifentanil (9739)
|
II
|
|
Sufentanil(9740)
|
II
|
|
Thebaine (9333)
|
II
|
The firm plans to manufacture the listed controlled substances for internal
use and for sale to other companies.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt Inc. to
manufacture the listed basic class of controlled substance is consistent with
the public interest at this time. DEA has investigated Mallinckrodt Inc. to
ensure that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's physical
security systems, verification of the company's compliance with State and local
laws, and a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823,
and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-9619 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
